Sale of dewormer without efficacy against Covid has billionaire revenues – 05/30/2021 -Panel SA

In one year, ivermectin, a dewormer also used in the treatment of scabies and lice, registered a significant increase in the number of units sold in the country, according to Iqvia, an institute specializing in pharmaceutical retail data. But what draws attention is the billionaire turnover.

Sales of the drug, which advocates of the so-called early treatment encourage, but has no proven efficacy against Covid-19, rose 750% in April 2021 compared to the same month last year, to 84 million units.

The jump in the value reached by retail sales was higher, 1.272%, on the same basis of comparison. The gain rose from R$116.3 million to R$1.6 billion.

with Mariana Grazini e Andressa Motter

LINK PRESENT: Did you like this column? Subscriber can release five free hits of any link per day. Just click on the blue F below.


The article from the source


Related Articles

Back to top button